Abstract
Cutibacterium avidum is a well-known skin commensal, that sometimes can cause superficial or invasive infections, including infectious endocarditis. Cases of C. avidum-induced infectious endocarditis of native heart valves, prosthetic valves or other cardiac implantable devices are described, which is associated with the biological feature of the pathogen with a tendency to form biofilms. The article presents a clinical case of infectious endocarditis, caused by C. avidum, associated with implantation of pacemaker in 42-yearold patient with a history of multiple drug hypersensitivity reactions to antibacterial drugs. This individual feature interfered with effective antibacterial therapy of local infection of the intracardiac device, which led to the development of infectious endocarditis with vegetations, required surgery with tricuspid valve repair and pacemaker replacement.
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia
-
1.
Demin A.A., Kobalava Z.D., Skopin I.I., Tyurin P.V., Boytsov S.A., Golukhova E.Z., et al. Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Russian journal of cardiology. 2022;27(10):5233. Russian.
DOI: 10.15829/15604071-2022-5233
-
2.
Khaloo P., Uzomah U.A., Shaqdan A., Ledesma P.A., Galvin J., Ptaszek L.M., et al. Outcomes of patients hospitalized with cardiovascular implantable electronic device-related infective endocarditis, prosthetic valve endocarditis, and native valve endocarditis: a nationwide study, 2003 to 2017. J Am Heart Assoc. 2022;11(17):e025600.
DOI: 10.1161/JAHA.122.025600
-
3.
Delgado V., Marsan Ajmone N., De Waha S., Bonaros N., Brida M., Burri H., et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM), Eur Heart J. 2023;44(39):3948-4042.
DOI: 10.1093/eurheartj/ehad193
-
4.
Mateos Gaitán R., Boix-Palop L., Muñoz García P., Mestres C.A., Marín Arriaza M., Pedraz Prieto Á., et al. Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study. Europace. 2020;22(7):10621070.
DOI: 10.1093/europace/euaa076
-
5.
Rezar R., Lichtenauer M., Haar M., Hödl G., Kern J.M., Zhou Z., et al. Infective endocarditis – a review of current therapy and future challenges. Hellenic J Cardiol. 2021;62(3):190-200.
DOI: 10.1016/j.hjc.2020.10
-
6.
Maurer S.M., Kursawe L., Rahm S., Prinz J., Zinkernagel A.S., Moter A., et al. Cutibacterium avidum resists surgical skin antisepsis in the groin-a potential risk factor for periprosthetic joint infection: a quality control study. Antimicrob Resist Infect Control. 2021;1;10(1):27.
DOI: 10.1186/s13756-021-00883-1
-
7.
Corvec S. Clinical and biological features of Cutibacterium (formerly Propionibacterium) avidum, an underrecognized microorganism. Clin Microbiol Rev. 2018 30;31(3):e00064-17.
DOI: 10.1128/CMR.00064-17
-
8.
Coenye T., Spittaels K.J., Achermann Y. The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes. Biofilm. 2021;9;4:100063.
DOI: 10.1016/j.bioflm.2021.100063
-
9.
Koizumi J., Nakase K., Hayashi N., Nasu Y., Hirai Y., Nakaminami H. Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections. J Glob Antimicrob Resist. 2022;28:151-157.
DOI: 10.1016/j.jgar.2021.12.021
-
10.
Doña I., Moreno E., Pérez-Sánchez N., Andreu I., Hernández Fernandez de Rojas D., Torres M.J. Update on quinolone allergy. Curr Allergy Asthma Rep. 2017;17(8):56.
DOI: 10.1007/s11882-017-0725-y
-
11.
Beloborodova N.V., Popov D.A., Vostrikova T.Yu., Bachinskaya E.N., Kuznetsova S.T. New indications for new fluoroquinolones: moxifloxacin in the treatment of nosocomial infections. Antibiotics and chemotherapy. 2009;54(1-2):25-30. Russian.
-
12.
Ilyina N.I., Zabolotskikh I.B., Astafieva N.G., Bayalieva A. Zh., Kulikov A.V., Latysheva T.V., et al. Anaphylactic shock. Clinical guidelines of Russian Association of Allergists and Clinical Immunologists and the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists”. Annals of critical care. 2020;3:1526. Russian.
DOI: 10.21320/1818-474X-2020-3-15-26
-
13.
Wijnakker R., van Maaren M.S., Bode L.G.M., Bulatovic M., Hendriks B.J.C., Loogman M.C.M., et al. The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy. Clin Microbiol Infect. 2023;29(7):863-875.
DOI: 10.1016/j.cmi.2023.04.008
-
14.
Sampedro M.F., Piper K.E., McDowell A., Patrick S., Mandrekar J.N., Rouse M.S., et al. Species of Propionibacterium and Propionibacterium acnes phylotypes associated with orthopedic implants. Diagn Microbiol Infect Dis. 2009;64(2):138-145.
DOI: 10.1016/j.diagmicrobio.2009.01.024
-
15.
Scholz C.F.P., Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol. 2016;66(11):4422-4432.
DOI: 10.1099/ijsem.0.001367
-
16.
Zeller V.A., Letembet V.A., Meyssonnier V.A., Heym B., Ziza J.M., Marmor S.D. Cutibacterium (formerly Propionibacterium) avidum: a rare but avid agent of prosthetic hip infection. J Arthroplasty. 2018;33(7):22462250.
DOI: 10.1016/j.arth.2018.02.008
-
17.
Cochrane N., Kim B., Kelly P., Seidelman J., Seyler T., Klifto C., et al. Cutibacterium positive cultures in total joint arthroplasty: a comparison of the hip, knee, and shoulder. Int Orthop. 2023;47(8):1939-1946.
DOI: 10.1007/s00264-023-05804-y
-
18.
Maurer S.M., Kursawe L., Rahm S., Prinz J., Zinkernagel A.S., Moter A., et al. Cutibacterium avidum resists surgical skin antisepsis in the groin – a potential risk factor for periprosthetic joint infection: a quality control study. Antimicrob Resist Infect Control. 2021;10:27.
DOI: 10.1186/s13756-021-00883-1
-
19.
Boman J., Nilson B., Sunnerhagen T., Rasmussen M. True infection or contamination in patients with positive Cutibacterium blood cultures – a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2022;41:1029-1037.
DOI: 10.1007/s10096-022-04458-9
-
20.
Legaria M.C., Barberis C., Camporro J., Traglia G.M., Famiglietti A., Stecher D., et al. Intra-peritoneal abscess after an abdominal hysterectomy involving Cutibacterium avidum (former Propionibacterium avidum) highly resistant to clindamycin. Anaerobe. 2019;59:176-183.
DOI: 10.1016/j.anaerobe.2019.06.013
-
21.
Clayton J.J., Baig W., Reynolds G.W., Sandoe J.A.T. Endocarditis caused by Propionibacterium species: a report of three cases and a review of clinical features and diagnostic difficulties. J Med Microbiol. 2006;55(Pt. 8):981-987.
DOI: 10.1099/jmm.0.46613-0
-
22.
Loureiro-Amigo J., Pons S., Sierra M., Meije Y. Prosthetic valve with infective endocarditis caused by Propionibacterium avidum. A case report. Enferm Infecc Microbiol Clin. 2017;35(3):196-197.
DOI: 10.1016/j.eimc.2016.08.010
-
23.
Caldara M., Belgiovine C., Secchi E., Rusconi R. Environmental, microbiological, and immunological features of bacterial biofilms associated with implanted medical devices. Clin Microbiol Rev. 2022;20;35(2):e0022120.
DOI: 10.1128/cmr.00221-20
-
24.
Lindell F., Söderquist B., Sundman K., Olaison L., Källman J. Prosthetic valve endocarditis caused by Propionibacterium species: a national registry-based study of 51 Swedish cases. Eur J Clin Microbiol Infect Dis. 2018;37(4):765771.
DOI: 10.1007/s10096-017-3172-8